Shay Capital’s Immunogen Inc IMGN Stock Holding History

Shay Capital’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,000	Closed	-$593K	–	500
2023 Q4	$593K	Sell	20,000 -48,500	-71%	-$966K	0.12%	118
2023 Q3	$1.09M	Buy	68,500 +26,000	+61%	+$432K	0.15%	105
2023 Q2	$802K	Buy	+42,500	New	+$502K	0.11%	119

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Shay Capital's IMGN Position: Q4 2023 in Review

Shay Capital sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 18,100 shares — an estimated $360K sold.

Shay Capital first reported a position in IMGN in Q3 2023 and held it in 1 quarter. The position peaked at $287K in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

Shay Capital reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
Shay Capital sold 18,100 Immunogen Inc shares in Q4 2023, an estimated $360K.
Shay Capital first reported a position in Immunogen Inc in Q3 2023 and held it in 1 quarter.
Shay Capital's Immunogen Inc position peaked at $287K in Q3 2023.
327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Shay Capital's 13F filing for Q4 2023, filed 14 Feb 2024.